Hydroxylamine → alpha-[(N,N-bis(2,2,6,6-tetramethylpiperidin-4-yl)aminocarbonyl)-methyl]-N-[2-(N,N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-aminocarbonyl)ethyl]nitrone

HRID 1073977Notes

Reaction equation

HRID 1073977 reaction equation
[CH3:1][C:2]1([CH3:52])[CH2:7][CH:6]([N:8]([CH:40]2[CH2:45][C:44]([CH3:47])([CH3:46])[NH:43][C:42]([CH3:49])([CH3:48])[CH2:41]2)[C:9]([CH2:11][CH2:12][N:13]([CH2:15][CH2:16][C:17]([N:19]([CH:30]2[CH2:35][C:34]([CH3:37])([CH3:36])[NH:33][C:32]([CH3:39])([CH3:38])[CH2:31]2)[CH:20]2[CH2:25][C:24]([CH3:27])([CH3:26])[NH:23][C:22]([CH3:29])([CH3:28])[CH2:21]2)=[O:18])[OH:14])=[O:10])[CH2:5][C:4]([CH3:51])([CH3:50])[NH:3]1.CC1(C)CC(N(C2CC(C)(C)NC(C)(C)C2)C(=O)C=C)CC(C)(C)N1.NO>>[CH3:26][C:24]1([CH3:27])[CH2:25][CH:20]([N:19]([CH:30]2[CH2:31][C:32]([CH3:39])([CH3:38])[NH:33][C:34]([CH3:37])([CH3:36])[CH2:35]2)[C:17]([CH2:16][CH:15]=[N+:13]([CH2:12][CH2:11][C:9]([N:8]([CH:40]2[CH2:41][C:42]([CH3:48])([CH3:49])[NH:43][C:44]([CH3:47])([CH3:46])[CH2:45]2)[CH:6]2[CH2:7][C:2]([CH3:1])([CH3:52])[NH:3][C:4]([CH3:50])([CH3:51])[CH2:5]2)=[O:10])[O-:14])=[O:18])[CH2:21][C:22]([CH3:29])([CH3:28])[NH:23]1

Participants

4

Procedure

Following the general procedure of Example 6, the title compound is prepared from N,N-bis[2-(N,N-bis(2,2,6,6-tetramethylpiperidin-4-yl)aminocarbonyl)ethyl]hydroxylamine. This intermediate is prepared from N,N-bis(2,2,6,6-tetramethylpiperidin-4-yl)acrylamide and hydroxylamine.

Sources & evidence

ORD record
ord-53055fb42621422c8dbf8accb1c72ecd
Source dataset
uspto-grants-1990_11
Patent number
US04972009

Reaction notes

Loading…